A tumor protein may help brain tumors spread
Original title: Host TLR4 activation by tenascin-C is associated with MMP14-dependent glioma invasion.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in tumor samples and in mouse brain slices and cells.
The short version
Lab tests suggest a protein made by brain tumors pushes nearby immune cells to help the tumor spread.
What was studied. Researchers looked at tumor tissue from people with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary and at large public data sets. They also used mouse brain slices and mouse brain immune cells, some of which lacked a protein called TLR4.
What they found. A tumor protein called tenascin-C was high in tumor tissue. It showed up most in the areas where the tumor was spreading and near blood vessels. Tumors with high tenascin-C and high MMP14 were linked to shorter survival. In mouse brain slices without TLR4, tumors grew and spread less.
What this means, and what it doesn't
What it could mean: This points to one possible way glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary spreads through the brain. It gives scientists a new path to study, and maybe a target for future drugs.
What it doesn't mean: This does not mean a new treatment is coming soon. The work was done in tumor samples, mouse brain slices, and mouse cells. No patient was treated. There is no drug that blocks this path today, and this is not a cure.
Source: PubMed, September 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.